We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abbott Labs Strikes Again Over Depakote ER

Law360 (July 10, 2008, 12:00 AM EDT) -- Abbott Laboratories has filed a patent suit against Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. to bar it from manufacturing a generic version of the anti-seizure drug Depakote ER that allegedly infringes four Abbott patents.

In a complaint filed Tuesday in the U.S. District Court for the District of New Jersey, Abbott alleges that Dr. Reddy's Laboratories Ltd. and co-defendant Dr. Reddy's Laboratories Inc., its wholly owned U.S.-based subsidiary, filed an abbreviated new drug application with the U.S. Food and Drug Administration to produce a generic...
To view the full article, register now.